- Home
- Publications
- Publication Search
- Publication Details
Title
Can the disease course in Parkinson’s disease be slowed?
Authors
Keywords
Disease course modification, Disease modifying therapies, Parkinson’s disease, Pathogenesis, Precision medicine, Therapy
Journal
BMC Medicine
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-10
DOI
10.1186/s12916-015-0534-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Is Neuroinflammation Involved in the Development of Dementia in Patients with Parkinson's Disease?
- (2013) In-Uk Song et al. INTERNAL MEDICINE
- Personalized Medicine in Neurodegenerative Diseases: How Far Away?
- (2013) Kristina Gotovac et al. Molecular Diagnosis & Therapy
- The role ofSCARB2as susceptibility factor in Parkinson's disease
- (2013) Franziska Hopfner et al. MOVEMENT DISORDERS
- The genetics of Parkinson's disease: Progress and therapeutic implications
- (2013) Andrew B. Singleton et al. MOVEMENT DISORDERS
- Genetic causes of Parkinson's disease and their links to autophagy regulation
- (2013) Ping-Yue Pan et al. PARKINSONISM & RELATED DISORDERS
- Silencing synuclein at the synapse with PLK2
- (2013) B. D. Looyenga et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
- (2012) Troy T. Rohn CNS & Neurological Disorders-Drug Targets
- Therapies in Parkinsonʼs disease
- (2012) Joseph Jankovic et al. CURRENT OPINION IN NEUROLOGY
- Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
- (2012) Dawn Béraud et al. Journal of Neuroimmune Pharmacology
- Parkinson's disease: Evidence for environmental risk factors
- (2012) Karl Kieburtz et al. MOVEMENT DISORDERS
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Lysosome-dependent pathways as a unifying theme in Parkinson's disease
- (2012) George K. Tofaris MOVEMENT DISORDERS
- Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease
- (2012) Philip WL Ho et al. Translational Neurodegeneration
- Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease
- (2011) Anil Kachroo et al. ANNALS OF NEUROLOGY
- The Mitochondrial Cascade Hypothesis for Parkinsons Disease
- (2011) Sandra M. Cardoso CURRENT PHARMACEUTICAL DESIGN
- Exploring the link between glucocerebrosidase mutations and parkinsonism
- (2011) Wendy Westbroek et al. TRENDS IN MOLECULAR MEDICINE
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Metabolomic Profiling in LRRK2-Related Parkinson's Disease
- (2009) Krisztina K. Johansen et al. PLoS One
- The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
- (2008) Garima Dutta et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Smoking and tea consumption delay onset of Parkinson's disease
- (2008) Boris Kandinov et al. PARKINSONISM & RELATED DISORDERS
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
- (2008) Claire Henchcliffe et al. Nature clinical practice. Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started